Nanoemulsions Encapsulate Anti-Oxidant Synergy Formulation (ASF) for Cancer Therapy

The Portal is a joint project of MATTO and the MTTC. The development and implementation of the portal has been paid for by the MTTC, Beth Israel Deaconess Medical Center, Boston Biomedical Research Institute, Boston University, Brandeis University, Caritas St. Elizabeth's Medical Center, Boston Children's Hospital, Dana Farber Cancer Institute, Harvard University, Joslin Diabetes Center, Massachusetts Eye and Ear Infirmary, Massachusetts General Hospital, McLean Hospital, Northeastern University, The Schepens Eye Research Institute, and Tufts University.

Intellectual Property

ID:		UML 05-17
IP Type:		Licensable Technology
Title:		Nanoemulsions Encapsulate Anti-Oxidant Synergy Formulation (ASF) for Cancer Therapy
Inventor:		Robert Nicolosi
Summary:		This invention utilizes nanoemulsions as a mechanism for delivering therapeutic formulations for the treatment of cancerous tumors. An antioxidant synergy formulation has been developed (ASF) which efficiently prevents the proliferation of cancerous cells in cell cultures and encourages cell differentiation. Tests performed for this invention show that the nanoemulsion encapsulate ASF preparation, significantly increases such formulations efficacy in reducing tumor cell growth.
Tech Type:		Nanotechnology/NEMS
URL:		http://www.uml.edu/cvip
Contact:		Susu Wong, 978 934 4722, susu_wong@uml.edu
Organization:		University of Massachusetts Lowell

Display all intellectual properties for Robert Nicolosi
Display all intellectual properties for University of Massachusetts Lowell